Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Apricus Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Apricus Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 11
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma 14
Apricus Biosciences Completes Acquisition Of NitroMist Rights From NovaDel Pharma For US$0.2 Million 15
Venture Financing 16
Apricus Biosciences Raises USD10 Million in Venture Financing 16
Partnerships 17
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 17
Apricus Biosciences Enters Into Co-Promotion Agreement With PediatRx For GRANISOL And AQUORAL 18
Merger 19
Apricus Biosciences to Merge with Seelos Therapeutics 19
Licensing Agreements 21
Apricus Biosciences Enters into Licensing Agreement with Allergan 21
Apricus Expands Licensing Agreement with Hexal for Vitaros 22
Apricus Biosciences Enters into Licensing Agreement with Forendo Pharma for Fispemifene 23
Apricus Biosciences Enters Into Licensing Agreement With Recordati For Vitaros 25
Apricus Biosciences Enters Into Licensing Agreement With Laboratoires Majorelle For Vitaros 26
Apricus Biosciences Enters Into Licensing Agreement With Takeda Pharma For Vitaros 27
Apricus Biosciences Enters Into Licensing Agreement With Elis Pharma For MycoVa 28
Apricus Biosciences Enters Into Licensing Agreement With Abbott Labs For Vitaros 29
Apricus Biosciences Enters Into Licensing Agreement With Stellar Pharma For MycoVa 30
Apricus Biosciences Expands Licensing Agreement With Hexal For Vitaros 31
Equity Offering 32
Apricus Biosciences Raises USD3.55 Milllion in Public Offering of Shares 32
Apricus Biosciences to Raise USD3.7 Million in Private Placement of Shares and Warrants 33
Apricus Biosciences Files Registration Statement for Public Offering of Shares for USD6.9 Million 34
Apricus Biosciences Raises USD3.7 Million in Registered Direct Offering 35
Apricus Biosciences to Raise up to USD7 Million in Private Placement of Shares 36
Apricus Biosciences Raises USD7.8 Million in Second and Final Tranche of Private Placement of Shares and Warrants 38
Apricus Biosciences Raises USD2.2 Million in First Tranche of Private Placement of Shares and Warrants 40
Apricus Biosciences Raises USD11 Million in Private Placement of Shares and Warrants 42
Apricus Biosciences Completes First Tranche of Private Placement of Shares for USD2 Million 43
Apricus Biosciences Completes Public Offering Of Shares For US$17 Million 44
Apricus Biosciences Announces Private Placement Of Shares For US$17.2 Million 46
Apricus Biosciences Completes Public Offering Of Units For US$20 Million 47
Asset Transactions 49
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 49
Biocodex Acquires Rights To Totect, Anthracycline Extravasation Medicine, From Apricus Biosciences 51
Mist Pharma Acquires Rights To NitroMist From Apricus Biosciences 52
Acquisition 53
Apricus Biosciences Completes Acquisition Of Finesco For Up To US$11 Million 53
Apricus Biosciences Inc – Key Competitors 54
Apricus Biosciences Inc – Key Employees 55
Apricus Biosciences Inc – Locations And Subsidiaries 56
Head Office 56
Other Locations & Subsidiaries 56
Recent Developments 57
Financial Announcements 57
Oct 31, 2018: Apricus Biosciences provides corporate update and third quarter 2018 financial results 57
Aug 09, 2018: Apricus Biosciences provides corporate update and second quarter 2018 financial results 58
May 03, 2018: Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results 59
Mar 01, 2018: Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2017 Financial Results 60
Nov 02, 2017: Apricus Biosciences Provides Corporate Update and Third Quarter 2017 Financial Results 61
Aug 02, 2017: Apricus Biosciences Provides Corporate Update and Second Quarter 2017 Financial Results 62
May 11, 2017: Apricus Biosciences Provides Corporate Update and First Quarter 2017 Financial Results 63
Mar 13, 2017: Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2016 Financial Results 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Apricus Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Apricus Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 10
Apricus Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 11
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma 14
Apricus Biosciences Completes Acquisition Of NitroMist Rights From NovaDel Pharma For US$0.2 Million 15
Apricus Biosciences Raises USD10 Million in Venture Financing 16
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 17
Apricus Biosciences Enters Into Co-Promotion Agreement With PediatRx For GRANISOL And AQUORAL 18
Apricus Biosciences to Merge with Seelos Therapeutics 19
Apricus Biosciences Enters into Licensing Agreement with Allergan 21
Apricus Expands Licensing Agreement with Hexal for Vitaros 22
Apricus Biosciences Enters into Licensing Agreement with Forendo Pharma for Fispemifene 23
Apricus Biosciences Enters Into Licensing Agreement With Recordati For Vitaros 25
Apricus Biosciences Enters Into Licensing Agreement With Laboratoires Majorelle For Vitaros 26
Apricus Biosciences Enters Into Licensing Agreement With Takeda Pharma For Vitaros 27
Apricus Biosciences Enters Into Licensing Agreement With Elis Pharma For MycoVa 28
Apricus Biosciences Enters Into Licensing Agreement With Abbott Labs For Vitaros 29
Apricus Biosciences Enters Into Licensing Agreement With Stellar Pharma For MycoVa 30
Apricus Biosciences Expands Licensing Agreement With Hexal For Vitaros 31
Apricus Biosciences Raises USD3.55 Milllion in Public Offering of Shares 32
Apricus Biosciences to Raise USD3.7 Million in Private Placement of Shares and Warrants 33
Apricus Biosciences Files Registration Statement for Public Offering of Shares for USD6.9 Million 34
Apricus Biosciences Raises USD3.7 Million in Registered Direct Offering 35
Apricus Biosciences to Raise up to USD7 Million in Private Placement of Shares 36
Apricus Biosciences Raises USD7.8 Million in Second and Final Tranche of Private Placement of Shares and Warrants 38
Apricus Biosciences Raises USD2.2 Million in First Tranche of Private Placement of Shares and Warrants 40
Apricus Biosciences Raises USD11 Million in Private Placement of Shares and Warrants 42
Apricus Biosciences Completes First Tranche of Private Placement of Shares for USD2 Million 43
Apricus Biosciences Completes Public Offering Of Shares For US$17 Million 44
Apricus Biosciences Announces Private Placement Of Shares For US$17.2 Million 46
Apricus Biosciences Completes Public Offering Of Units For US$20 Million 47
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 49
Biocodex Acquires Rights To Totect, Anthracycline Extravasation Medicine, From Apricus Biosciences 51
Mist Pharma Acquires Rights To NitroMist From Apricus Biosciences 52
Apricus Biosciences Completes Acquisition Of Finesco For Up To US$11 Million 53
Apricus Biosciences Inc, Key Competitors 54
Apricus Biosciences Inc, Key Employees 55
Apricus Biosciences Inc, Subsidiaries 56
List of Figures
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Apricus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Apricus Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 11